|
|
|
|
|
|
|
|
|
|
Rv2043c More about Rv2043c on TBDB.org More about Rv2043c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv2043c: Codons 10 to 14: 12 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Scorpio A AAC 1997 | del C | 28 | 10 | Frameshift | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 1/0 | - | - |
| Marttila HJ AAC 1999 | CAA/AAA | 28 | 10 | Gln/Lys | 1994-1997 | Russia | Sequencing | Whole gene | Z | - | BACTEC 460 | 36/44 | 1/0 | not tested | - |
| Marttila HJ AAC 1999 | CAA/TAA | 28 | 10 | Gln/STOP | 1994-1997 | Russia | Sequencing | Whole gene | Z | - | BACTEC 460 | 36/44 | 1/0 | not tested | - |
| Cheng SJ AAC 2000 | CAG/CGA | 29 | 10 | Gln/Arg | 1990-1992 | USA | Sequencing | Whole gene | ZHREO | >900 | Proportion method, BACTEC 460 | 59/59 | 1/0 | - | - |
| Hirano K TLD 1997 | CAG/CCG | 29 | 10 | Gln/Pro | 1997 | Myanmar | Sequencing | Whole gene | ZHRSE | >800 | Proportion method | 33/168 | 1/0 | - | ![]() |
| Morlock GP AAC 2000 | CAG/CCA | 29 | 10 | Gln/Pro | 1999 | - | Sequencing | Whole gene | Z | 800 | Proportion method | 37/60 | 1/0 | - | - |
| Scorpio A AAC 1997 | GAC/AAC | 34 | 12 | Asp/Asn | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 1/0 | - | - |
| Scorpio A AAC 1997 | GAC/GCC | 35 | 12 | Asp/Ala | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 1/0 | - | ![]() |
| Lemaitre N AAC 1999 | TTC/TCC | 38 | 13 | Phe/Ser | 1987 | France | Sequencing | Whole gene | ZHRES | >2000 | - | 19/35 | 1/0 | - | - |
| Scorpio A AAC 1997 | TGC/CGC | 40 | 14 | Cys/Arg | 1992-1995 | - | PCR-SSCP | Whole gene | Z | >900ug/ml | Pzase testing by Wayne's method | 46/46 | 1/0 | - | ![]() |
| Louw GE Int J Tuberc Lung Dis 2006 | TGC/CGC | 40 | 14 | Cys/His | 2001-2002 | South Africa | Sequencing | Whole gene | ZHRSEthK | - | BACTEC MGIT 960 | 115 | 68 | - | ![]() |
| Lee KW J Korean Med Sci 2001 | TGC/TAC | 41 | 14 | Cys/Tyr | 2001 | South korea | Sequencing | Whole gene | Z | - | PZase test with Wayne's method | 92/95 | 1/0 | - | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |